Increased nuclear YAP1 levels have been found in solid tumors, and various Hippo pathway constituents have been altered in human cancer at the DNA level, including YAP1 and TAZ gene amplification, deletions, or truncating mutations in NF2, LATS1, and LATS2 gene [21, 22]. The gene discussed is NF2; the disease is cancer.